BACKGROUND & AIMS: Inflammation and impaired hepatocyte regeneration contribute to liver failure in alcoholic hepatitis (AH). Interleukin (IL)-1 is a key inflammatory cytokine in the pathobiology of AH. The role of IL-1 in liver regeneration in the recovery phase of alcohol-induced liver injury is unknown. METHODS: In this study, we tested IL-1 receptor antagonist to block IL-1 signalling in a mouse model of acute-on-chronic liver injury on liver inflammation and hepatocyte regeneration in AH. RESULTS: We observed that inhibition of IL-1 signalling decreased liver inflammation and neutrophil infiltration, and resulted in enhanced regeneration of hepatocytes and increased rate of recovery from liver injury in AH. CONCLUSION: Our novel findings suggest that IL-1 drives sustained liver inflammation and impaired hepatocyte regeneration even after cessation of ethanol exposure.
BACKGROUND & AIMS:Inflammation and impaired hepatocyte regeneration contribute to liver failure in alcoholic hepatitis (AH). Interleukin (IL)-1 is a key inflammatory cytokine in the pathobiology of AH. The role of IL-1 in liver regeneration in the recovery phase of alcohol-induced liver injury is unknown. METHODS: In this study, we tested IL-1 receptor antagonist to block IL-1 signalling in a mouse model of acute-on-chronic liver injury on liver inflammation and hepatocyte regeneration in AH. RESULTS: We observed that inhibition of IL-1 signalling decreased liver inflammation and neutrophil infiltration, and resulted in enhanced regeneration of hepatocytes and increased rate of recovery from liver injury in AH. CONCLUSION: Our novel findings suggest that IL-1drives sustained liver inflammation and impaired hepatocyte regeneration even after cessation of ethanol exposure.
Authors: Christian Klein; Torsten Wüstefeld; Ulrike Assmus; Tania Roskams; Stefan Rose-John; Michael Müller; Michael P Manns; Mattias Ernst; Christian Trautwein Journal: J Clin Invest Date: 2005-03-03 Impact factor: 14.808
Authors: Arvin Iracheta-Vellve; Jan Petrasek; Benedek Gyongyosi; Abhishek Satishchandran; Patrick Lowe; Karen Kodys; Donna Catalano; Charles D Calenda; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Gyongyi Szabo Journal: J Biol Chem Date: 2016-11-03 Impact factor: 5.157
Authors: David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal Journal: Hepatology Date: 2005-06 Impact factor: 17.425
Authors: Suraj J Patel; Jay Luther; Stefan Bohr; Arvin Iracheta-Vellve; Matthew Li; Kevin R King; Raymond T Chung; Martin L Yarmush Journal: Clin Transl Gastroenterol Date: 2016-03-17 Impact factor: 4.488
Authors: Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto Journal: Nat Rev Dis Primers Date: 2018-08-16 Impact factor: 52.329
Authors: Matias A Avila; Jean-François Dufour; Alexander L Gerbes; Fabien Zoulim; Ramon Bataller; Patrizia Burra; Helena Cortez-Pinto; Bin Gao; Ian Gilmore; Philippe Mathurin; Christophe Moreno; Vladimir Poznyak; Bernd Schnabl; Gyongyi Szabo; Maja Thiele; Mark R Thursz Journal: Gut Date: 2019-12-26 Impact factor: 23.059
Authors: Patrick P Lowe; Yeonhee Cho; David Tornai; Sahin Coban; Donna Catalano; Gyongyi Szabo Journal: Alcohol Clin Exp Res Date: 2020-01-09 Impact factor: 3.455
Authors: Sophia M Schmitz; Henriette Dohmeier; Christian Stoppe; Patrick H Alizai; Sandra Schipper; Ulf P Neumann; Mark Coburn; Tom F Ulmer Journal: Int J Mol Sci Date: 2020-07-30 Impact factor: 5.923